SVLSF IV, LLC → KalVista Pharmaceuticals, Inc. KALV

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

0 buys · 0 sales · 4 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 15.92

20,359,503 shares short · +4.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $36.88M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-16	Piekos Brian	officer	Option exercise	6,250	—	—
2026-04-16	Audhya Paul K.	officer	Option exercise	6,250	—	—
2026-04-16	Sweeny Nicole	officer	Option exercise	6,250	—	—
2026-04-16	Palleiko Benjamin L	director, officer	Option exercise	20,312	—	—

Other 13D/G Filings on KalVista Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2024-04-01	SC	TCG Crossover GP I, LLC	—	—	view →
2019-04-24	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-04-15	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-03-20	SC	SVLSF IV, LLC	—	—	view →

Other Filings by SVLSF IV, LLC

Filed	Form	Issuer	Stake	Shares
2019-03-20	SC	KalVista Pharmaceuticals, Inc. KALV	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →